Health Cor Management, L.P. Blueprint Medicines Corp Transaction History
Health Cor Management, L.P.
- $106 Million
- Q4 2022
A detailed history of Health Cor Management, L.P. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Health Cor Management, L.P. holds 30,000 shares of BPMC stock, worth $2.9 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
30,000
Previous 104,600
71.32%
Holding current value
$2.9 Million
Previous $6.89 Million
80.93%
% of portfolio
1.24%
Previous 0.86%
Shares
8 transactions
Others Institutions Holding BPMC
# of Institutions
346Shares Held
62.5MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$642 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$632 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$567 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$313 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$238 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.77B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...